21 May 2009
Liver transplantation in children with biliary atresia and polysplenia syndrome
D Broniszczak, A Apanasiewicz, H Ismail, A Chyżyńska, P Czubkowski, P KalicińskiAnn Transplant 2009; 14(1): 28-28 :: ID: 880298
Abstract
Background: Children with biliary atresia (BA) and polysplenia syndrome (PS)
have always been considered as a high risk liver transplant recipients due to
technical problems during transplant surgery. We report a single-centre experience with the liver transplantation in children with this syndrome.
Material/Methods: Between 2000 and 2008 330 liver transplants were performed in our centre in children, among them there were five with end stage liver insufficiency, with BA and PS, following the Kasai procedure. They underwent liver transplantation from living (4 patients) and deceased donors
(1 patient). All patients demonstrated additional malformations like: absence of retrohepatic vena cava (1), intestinal malrotation (2), preduodenal portal vein (1), hepatic artery (2) and cardiac anomalies (2). No situs inversus occurred. Transplantations were performed at the age ranging from 8 months to 11 years. We did not meet serious technical problems during operation, as well as never had to use vascular conduits for graft revascularization.
Results: All patents are alive and well with follow up between 9 and 105 months after transplantation, although one is with persistent hepatitis C and one has symptoms of portal hypertension after portal thrombosis which occurred during PTLD treatment one year after transplantation.
Conclusions: Results of liver transplantation in children with BA and PS syndrome are as good as for other indications for non-syndromic BA in experienced paediatric liver transplant centre.
Keywords: Liver Transplantation
In Press
Case report
Pulmonary Embolism Following Living Donor Hepatectomy: A Report of 4 Cases and Literature ReviewAnn Transplant In Press; DOI: 10.12659/AOT.946752
Most Viewed Current Articles
03 Jan 2023 : Original article 6,527
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
15 Aug 2023 : Review article 6,222
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
16 May 2023 : Original article 6,152
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
17 Jan 2023 : Original article 5,279
Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation i...DOI :10.12659/AOT.938595
Ann Transplant 2023; 28:e938595